 Notably, it does not completely substitute for the prototypical KOR agonist U-50488 in rodents, indicating qualitative differences in the discriminative effects of the two compounds.Moreover, unlike U-50488, it produces neither conditioned place aversion or preference in rodents.The drug is a 4,5-epoxymorphinan derivative, and is structurally unique relative to other KOR agonists.